Monocyte-derived multipotent cell delivered programmed therapeutics to reverse idiopathic pulmonary fibrosis

Authors: Xin Chang, Lei Xing, Yi Wang, Chen-Xi Yang, Yu-Jing He, Tian-Jiao Zhou, Xiang-Dong Gao, Ling Li, Hai-Ping Hao, Hu-Lin Jiang

Published: 2020-05-27

DOI: 10.1126/sciadv.aba3167

Source: Full article

---

Abstract

This study presents the cell-mediated drug-loaded nanoparticle strategy for selective drugs delivery to treat lung fibrosis.